Priming of Eosinophil Recruitment in Vivo by LPS Pretreatment

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1684-1692

  Macari, David M T ^a   Teixeira, Mauro M ^a   Hellewell, Paul G ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 2 QUINOLONE; APAFANT; AZEPINE DERIVATIVE; CD18 ANTIGEN; COMPLEMENT COMPONENT C5A [DEARGININE]; CYCLOHEXIMIDE; EOSINOPHIL CHEMOTACTIC FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOCYTE ANTIGEN; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; MONOCLONAL ANTIBODY; PROTEIN SYNTHESIS INHIBITOR; PYRAN DERIVATIVE; QUINOLONE DERIVATIVE; SIALOGLYCOPROTEIN; THROMBOCYTE ACTIVATING FACTOR; TRIAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; ZYMOSAN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EDEMA; EOSINOPHIL; EOSINOPHILIA; FEMALE; GENETICS; GUINEA PIG; IMMUNOLOGY; LEUKOCYTE COUNT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PASSIVE SKIN ANAPHYLAXIS; PATHOLOGY; PATHOPHYSIOLOGY; SKIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD18; AZEPINES; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C5A, DES-ARGININE; CYCLOHEXIMIDE; DRUG SYNERGISM; EDEMA; EOSINOPHILIA; EOSINOPHILS; FEMALE; GUINEA PIGS; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKOCYTE COUNT; LEUKOTRIENE B4; LIPOPOLYSACCHARIDES; LIPOXYGENASE INHIBITORS; NEUTROPHILS; PASSIVE CUTANEOUS ANAPHYLAXIS; PLATELET ACTIVATING FACTOR; PROTEIN SYNTHESIS INHIBITORS; PYRANS; QUINOLONES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT FUSION PROTEINS; SIALOGLYCOPROTEINS; SKIN; TRIAZOLES; ZYMOSAN;

EID: 0030586678     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Butterfield, J. H., and K. M. Leiferman. 1993. Eosinophil-associated diseases. In Immunopharmacological of Eosinophils. H. Smith and R. M. Cook, eds. Academic Press, London, p. 152.
2. Butterworth, A. E., and K. J. I. Thorne. 1993. Eosinophils and parasitic diseases. In Immunophannacology of Eosinophils. H. Smith and R. M. Cook, eds. Academic Press, London, p. 119.
3. Gleich, G. J., N. A. Flavahan, T. Fujisawa, and P. M. Vanhoutte. 1988. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J. Allergy Clin. Immunol. 81:776.
4. 111In-eosinophils induced by inflammatory mediators in vivo. Immunology 73:222.
5. Collins, P. D., V. B. Weg, L. H. Faccioli, M. L. Watson, R. Moqbel, and T. J. Williams. 1993. Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology 79:312.
6. Teixeira, M. M., T. J. Williams, and P. G. Hellewell. 1993. E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea pig skin. Br. J. Pharmacol. 110:416.
7. Teixeira, M. M., and P. G. Hellewell. 1994. Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea pig. Br. J. Pharmacol. 111:1205.
8. 111In-eosinophils accumulation in passive cutaneous anaphylatic reactions in the guinea pig. Br. J. Pharmacol. 113:35.
9. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881.
10. Teixeira, M. M., S. Reynia, M. Robinson, A. Shock, T. J. Williams, F. M. Williams, A. G. Rossi, and P. G. Hellewell. 1994. Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea pig skin. Br. J. Pharmacol 111:811.
11. Hallet, M. B., and D. Lloyds. 1995. Neutrophil priming: the cellular signals that say 'amber' hut not green. Immunol. Today 16:264.
12. Moser, R., J. Fehr, L. Oligiati, and P. L. B. Bruijnzeel. 1992. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 79:2937.
13. Warringa, R. A. J., H. J. J. Mengelers, P. H. M. Kuijper, J. A. M. Raaijmakers, P. L. B. Bruijnzeel, and L. Koenderman. 1992. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 79:1836.
14. Warringa, R. A. J., H. J. J. Mengelers, J. A. M. Raaijmakers, P. L. B. Bruijnzeel. and L. Koenderman. 1993. Allergens, IgE, mediators, inflammatory mechanisms: upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J. Allergy Clin. Immunol. 91:1198.
15. Warringa, R. A. J., L. Koenderman, P. T. M. Kok, J. Kreukniet, and P. L. B. Bruijnzeel. 1991. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulaling factor and interleukin-3. Blood 77:2694.
16. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A. B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952.
17. Warringa, R. A. J., R. C. Schweizer, T. Maikoe, P. H. M. Kuijper, P. L. B. Bruijnzeel, and L. Koenderman. 1992. Modulation of eosinophil chemotaxis by interleukin-5. Am. J. Respir. Cell Mol. Biol. 7:631.
18. Pabst, M. 1994. Priming of neutrophils. In Immunopharmacological of Neutrophils. P. G. Hellewell and T. J. Williams, eds. Academic Press, London, p. 195.
19. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177:511.
20. Michel, O., R. Ginanni, J. Duchateau, F. Vertongen, B. Le Bon, and R. Sergysels. 1991. Domestic endotoxin exposure and clinical severity of asthma. Clin. Exp. Allergy 21:441.
21. Schwartz, D. A., P. S. Thorne, S. J. Yagla, L. F. Burmeister, S. A. Olenchock, J. L. Watt, and T. J. Quinn. 1995. The role of endotoxin in grain dust-induced lung disease. Am. J. Respir. Crit. Care Med 152:603.
22. Folkerts, G., P. A. J. Henricks, P. J. Slootweg, and F. P. Nijkamp. 1988. Endotoxin-induced inflammation and injury of the guinea pig respiratory airways cause bronchial hyporeactivity. Am. Rev. Respir. Dis. 137:1441.
23. Rylander, R., L. Beijer, R. Clark Lantz, R. Burrel, and P. Sedivy. 1988. Modulation of pulmonary inflammation after endotoxin inhalation with platelet-activating factor antagonist (48740 RP). Int. Arch. Allergy Appl. Immunol. 86:303.
24. Pauwels, R. A., J. C. Kips, R. A. Peleman, and M. E. van der Straeten. 1990. The effect of endotoxin inhalation on airway responsiveness and cellular influx in rats. Am. Rev. Respir. Dis. 141:540.
25. Bozza, P. T., H. C. Castro-Faria-Neto, M. A. Martins, A. P. Larangeira, J. E. Perales, P. M. R. Silva, and R. S. Cordeiro. 1993. Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat: a role for a newly generated protein. Eur. J. Pharmacol. 248:41.
26. 111In-eosinophil accumulation in guinea-pig skin: evidence for a role for TNFα. Immunology 84:36.
27. Milne, A. A. Y., and P. J. Piper. 1994. The effects of two anti-CD18 antibodies on antigen-induced airway hyperresponsiveness and leukocyte accumulation in the guinea pig. Am. J. Respir. Cell MoL. Biol. 11:337.
28. Andrew, D., A. Shock, E. Ball, S. Ortlepp, J. Bell, and M. Robinson. 1993. KIM185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion. Eur. J. Immunol. 23:2217.
29. Rampart, M., and T. J. Williams. 1988. Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo. Br. J. Pharmacol. 94:1143.
30. Watson, M. L., D. Smith, A. D. Bourne, R. C. Thompson, and J. Westwick. 1993. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 8:365.
31. Von Uexkull, C., S. Nourshargh, and T. J. Williams. 1992. Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist. Immunology 77:483.
32. Teixeira, M. M., T. J. Williams, and P. G. Hellewell. 1993. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea pig skin. Br. J. Pharmacol. 110:1515.
33. Pons, F., T. J. Williams, and J. B. Warren. 1993. Nitric oxide, but not interleukin-1, mediates the local blood flow response to lipopolysaccharide in rabbit skin. Eur. J. Pharmacol. 219:23.
34. Drake, W. T., and A. C. Issekutz. 1993. Transforming growth factor-α1 enhances polymorphonuclear leukocyte accumulation in dermal inflammation and transendothelial migration by a priming action. Immunology 78:197.
35. 4. J. Clin. Invest. 83:970.
36. Bozza, P. T., H. C. Castro-Faria-Neto, C. Penido, A. P. Larangeira, M. G. M. O. Henriques, P. M. R. Silva, M. A. Martins, R. R. Santos, and R. S. B. Cordeiro. 1994. Requirement for lymphocytes and resident macrophages in LPS-induced pleural eosinophil accumulation. J. Leukocyte Biol. 56:151.
37. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunological inducible TNF-α/cachetin. Nature 346:274.
38. Brzezinska-Blasczyk, E., A. Gaik, M. Czuwaj, and P. Kuna. 1988. Histamine release from human pulmonary mast cells induced by bacterial antigens. Allergol. Immunopathol. 16:375.
39. Church, M. K., S. Norn, G. J.-K. Pao, and S. T. Holgate. 1987. Non-IgE-dependent bacteria-induced histamine release from human lung and tonsillar mast cells. Clin. Allergy 17:341.
40. Leal-Burumen, I., P. Conlon, and J. S. Marshall. 1994. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152:5468.
41. Kyan-Aung, U., D. O. Haskard, R. N. Poston, M. H. Thornhill, and T. H. Lee. 1991. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J. Immunol. 146:521.
42. Gotsch, U., U. Jager, M. Dominis, and D. Vestweber. 1994. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-α in vivo. Cell Adhes. Commun. 2:7.
43. Coughlan, A., H. Hau, L. Dunlop, M. Berndt, and W. Hancock. 1994. P-selectin and PAF mediate initial endotoxin-induced neutropenia. J. Exp. Med. 179:329.
44. Sako, D., X. J. Chang, K. M. Barone, G. Vachino, H. M. White, G. Shaw, G. M. Veldman, K. M. Bean, T. G. Ahern, B. Furie, P. A. Cumming, and G. R. Larsen. 1993. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75:1179.
45. Yan, H-C., I. Juhasz, J. Pilewski, G. F. Murphy, M. Herlyn, and S. M. Albelda. 1993. Human/severe combined immunodeficiency mouse chimeras: an experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J. Clin. Invest. 91:986.
46. Keelan, E. T. M., S. T. License, A. M. Peters, R. M. Binns, and D. O. Haskard. 1994. Characterization of E-selectin expression in vivo with the use of a radio-labelled monoclonal antibody. Am. J. Physiol. 266:H278.
47. Weg, V. B., T. J. Williams, R. R. Lobb, and S. Nourshargh. 1993. A monoclonal antibody recognising very late activation antigen-4 (VLA-4) inhibits eosinophil accumulation in vivo. J. Exp. Med. 177:561.
48. Zeck-Kapp, G., W. Czech, and A. Kapp. 1994. TNF alpha-induced activation of eosinophil oxidative metabolism and morphology: comparison with IL-5. Exp. Dermatol. 3:176.
49. Nagata, M., T. Fukuda, T. Numao, S. Makino, and Y. Dohi. 1993. Tumor necrosis factor alpha induces migration of human eosinophils. Jpn. J. Allergol. 42:549.